Showing results (71-80 of 147) with videos related to
Sort By:
Pageof 15
Bioconjugate Chemistry|December 22, 2025
Development of a Long-Acting and Stapled Dual Amylin and Calcitonin Receptor Agonist as Monotherapy and Combination with GLP-1R Agonists for the Treatment of ObesityYaqi Zhou, Pu Xu, Jiang Lu, et al.AI Zheng = Aizheng = Chinese Journal of Cancer|December 14, 2002
[Surgical margin to direct the treatment and predict the prognosis of laryngeal carcinoma after partial laryngectomy]Guang-pu Xu, Zong-yuan Zeng, Liang-ping Xia, et al.Zhonghua Er Bi Yan Hou Ke Za Zhi|August 2, 2003
[Correlation between prognosis and the expression of eukaryotic translation initiation factor 4E in surgical margin specimen of laryngeal squamous cell carcinoma]Liang-ping Xia, Guang-pu Xu, Zong-yuan Zeng, et al.Zhonghua Er Bi Yan Hou Ke Za Zhi|October 1, 2003
[Distant metastases and their significant indicators in laryngeal cancer]Wei-wei Liu, Zong-yuan Zeng, Zhu-ming Guo, et al.Inorganic Chemistry|April 16, 2021
A Thermally and Chemically Stable Copper(II) Metal-Organic Framework with High Performance for Gas Adsorption and SeparationZhi Long Ma, Pu Xu Liu, Zhong Yi Liu, et al.AI Zheng = Aizheng = Chinese Journal of Cancer|January 2, 2003
[Factoral analysis related to primary recurrence of laryngeal squamous cell carcinomas after treatment]Zhu-ming Guo, Zong-yuan Zeng, Fu-jin Chen, et al.Animals : an Open Access Journal From MDPI|July 27, 2022
In Silico Screening and Development of Microsatellite Markers for Genetic Analysis in Perca fluviatilisPu Xu, Cuiyun Lu, Zhipeng Sun, et al.AI Zheng = Aizheng = Chinese Journal of Cancer|January 2, 2003
[Influence of induction chemotherapy on long-time effect of patients with tongue squamous cell carcinoma]Hui Hua, Zong-yuan Zeng, Hua Zhao, et al.Chemical Science|August 29, 2025
Cascade-activatable NIR-II fluorescent carbonic anhydrase inhibitors for imaging-guided cuproptosis/chemodynamic combination therapy of colorectal cancerPu Xu, Yuxin Huang, Gaoyuan Liu, et al.Fitoterapia|April 5, 2023
Loureirin C, from Chinese Dragon's Blood (Dracaena cochinchinensis S.C. Chen), is a novel selective estrogen receptor α modulator with anti-Alzheimer's disease effectsPu Xu, Shaoyun Li, Qing Wu, et al.Pageof 15